Showing results for:
Drug name(s)
Leukeran® Chlorambucil
Approved for
- Leukemia
- Chronic Lymphocytic Leukemia (CLL/SLL)
- Lymphoma
- Hodgkin Lymphoma (HL)
- Non-Hodgkin Lymphoma (NHL)
Drug name(s)
Leustatin® 2-CdA Cladribine
Approved for
- Leukemia
- Hairy Cell Leukemia (HCL)
- Lymphoma
Drug name(s)
Cytosar-U® Cytosine arabinoside Ara-C Cytarabine Liposomal cytarabine DepoCyt®
Approved for
- Leukemia
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Myeloid Leukemia (CML)
- Lymphoma
Drug name(s)
Denileukin diftitox-cxdl Lymphir™
Approved for
- Non-Hodgkin Lymphoma (NHL)
Drug name(s)
Revlimid® Lenalidomide
Approved for
- Leukemia
- Chronic Lymphocytic Leukemia (CLL/SLL)
- Lymphoma
- Follicular Lymphoma (FL)
- Mantle Cell Lymphoma (MCL)
- Marginal Zone Lymphoma (MZL)
- Myeloma
- Myelodysplastic Syndromes (MDS)
Drug name(s)
Folinic acid Leucovorin Levoleucovorin Fusilev®
Approved for
- Other Blood Cancers
Drug name(s)
Lynozyfic™ Linvoseltamab-gcpt
Approved for
- Myeloma
Drug name(s)
Doxil® Liposomal doxorubicin
Approved for
- Myeloma
Drug name(s)
Breyanzi® Lisocabtagene maraleucel
Approved for
- Leukemia
- Chronic Lymphocytic Leukemia (CLL/SLL)
- Lymphoma
- Follicular Lymphoma (FL)
- Mantle Cell Lymphoma (MCL)
Drug name(s)
CeeNU® CCNU Lomustine
Approved for
- Lymphoma
- Hodgkin Lymphoma (HL)
Drug name(s)
Zynlonta™ Loncastuximab tesirine-lpyl
Approved for
- Lymphoma
- Diffuse Large B-cell Lymphoma (DLBCL)
- High-grade B-cell Lymphoma with double or triple hits (HBL)
Drug name(s)
Reblozyl® Luspatercept-aamt
Approved for
- Myelodysplastic Syndromes (MDS)
- Myeloproliferative Neoplasms (MPN)
Drug name(s)
Mosunetuzumab-axgb Lunsumio® Lunsumio VELO™
Approved for
- Lymphoma
- Non-Hodgkin Lymphoma (NHL)
- Follicular Lymphoma (FL)
Drug name(s)
Leukine ® GM-CSF Sargramostim
Approved for
- Leukemia
- Acute Myeloid Leukemia (AML)